Coromandel International Ltd Upgraded to Sell on Technical Improvements Despite Financial Challenges

Quality Assessment: Mixed Signals Amid Operational Pressures

Coromandel International’s quality metrics present a complex picture. The company boasts a high return on equity (ROE) of 19.79%, signalling strong management efficiency and effective utilisation of shareholder capital. This is a positive indicator in the fertilisers industry, where operational excellence is critical. However, the recent quarterly financial results for Q4 FY25-26 have been disappointing. The company reported a 42.5% decline in profit after tax (PAT), down to ₹175.46 crores, signalling significant pressure on earnings.

Interest expenses have risen sharply by 32.72% over nine months to ₹274.63 crores, which has compressed operating profit to interest coverage to a low of 5.46 times. This deterioration in financial health undermines the quality rating, despite the strong ROE. Additionally, promoter confidence appears to be waning, with a 0.51% reduction in promoter stake in the last quarter, now standing at 56.35%. This reduction may reflect concerns about the company’s near-term outlook.

Valuation: Premium Pricing Amidst Profitability Concerns

Coromandel International is currently trading at a premium valuation, with a price-to-book (P/B) ratio of 4.7, which is considered very expensive relative to its sector peers. The stock’s price of ₹1,988.05 is well below its 52-week high of ₹2,720 but remains elevated given the recent earnings decline. The company’s price-to-earnings growth (PEG) ratio stands at 2.7, indicating that the market is pricing in significant growth expectations despite the recent negative returns.

Over the past year, the stock has underperformed the broader market, delivering a negative return of -13.79% compared to the BSE500’s -0.51%. This underperformance, coupled with rising interest costs and falling profits, suggests that the premium valuation is not fully justified by current fundamentals. Investors should be cautious given the stretched valuation metrics amid a challenging earnings environment.

Financial Trend: Earnings Pressure Despite Sector Leadership

Coromandel International is the largest company in the fertilisers sector by market capitalisation, valued at approximately ₹58,650 crores, representing 28.02% of the sector’s total market cap. Its annual sales of ₹31,479.54 crores account for 19.27% of the industry, underscoring its dominant position. However, the recent financial trend has been negative. Despite a 11.1% rise in profits over the past year, the stock’s price has declined by 13.79%, reflecting investor scepticism.

The company remains net-debt free, which is a positive financial attribute, but rising interest expenses and falling quarterly PAT highlight operational challenges. The operating profit to interest ratio at 5.46 times is the lowest recorded, signalling increased financial strain. These factors contribute to a cautious outlook on the company’s financial trajectory.

Long-term returns tell a more optimistic story, with Coromandel delivering a 10-year return of 695.38%, significantly outperforming the Sensex’s 185.35% over the same period. The 3-year and 5-year returns of 111.78% and 133.11% respectively also surpass market benchmarks, indicating strong historical growth despite recent setbacks.

Technical Analysis: Shift from Bearish to Mildly Bearish Supports Upgrade

The primary driver behind the upgrade from Strong Sell to Sell is an improvement in the technical outlook. The technical grade has shifted from bearish to mildly bearish, reflecting a more constructive price action pattern. Key technical indicators show a mixed but improving trend:

• MACD is bearish on a weekly basis but only mildly bearish monthly, indicating some easing of downward momentum.
• Relative Strength Index (RSI) shows no clear signal on both weekly and monthly charts, suggesting a neutral momentum phase.
• Bollinger Bands remain mildly bearish on both weekly and monthly timeframes, signalling some volatility but less severe than before.
• Moving averages on the daily chart are mildly bearish, indicating short-term caution.
• KST (Know Sure Thing) indicator is mildly bullish weekly but mildly bearish monthly, reflecting mixed momentum signals.
• Dow Theory analysis shows a mildly bullish weekly trend but mildly bearish monthly trend, reinforcing the mixed technical picture.
• On-Balance Volume (OBV) is neutral weekly but mildly bearish monthly, suggesting volume trends are not strongly supportive.

Price action today reflects this technical improvement, with the stock rising 3.78% to ₹1,988.05, trading near its intraday high of ₹1,999.00. The 52-week trading range remains wide, with a low of ₹1,709.50 and a high of ₹2,720.00, indicating significant volatility over the past year.

Comparative Performance and Market Context

When compared to the Sensex, Coromandel International has demonstrated superior short-term returns. Over the past week, the stock surged 13.85%, significantly outperforming the Sensex’s 3.73% gain. Similarly, the one-month return of 6.51% also outpaces the Sensex’s 1.36%. However, the year-to-date and one-year returns remain negative at -12.55% and -13.79% respectively, underperforming the Sensex’s -10.51% and -5.98% returns.

This divergence highlights the stock’s volatility and the mixed sentiment among investors. While technical indicators suggest a mild recovery, fundamental concerns and valuation premiums continue to temper enthusiasm.

Conclusion: Cautious Optimism Amidst Challenges

Coromandel International Ltd’s upgrade from Strong Sell to Sell reflects a cautious optimism driven primarily by technical improvements. The shift from a bearish to a mildly bearish technical stance has provided some relief to investors, supporting a less negative rating. However, the company’s financial performance remains under pressure, with declining quarterly profits, rising interest costs, and reduced promoter confidence.

Valuation remains a concern, with the stock trading at a premium to peers despite recent earnings weakness. Investors should weigh the company’s strong historical returns and sector leadership against the current operational and financial challenges. The stock may appeal to those with a higher risk tolerance looking for a potential turnaround, but a conservative approach remains warranted given the mixed signals.

Overall, the Sell rating reflects a balanced view that acknowledges technical progress while recognising the need for fundamental recovery before a more positive outlook can be justified.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today